Obesity is a complex, chronic disease that currently affects more than 40% of adults in the United States with another 30% estimated to have preobesity (overweight)
By mimicking the action of the glucagon-like peptide-1 (GLP-1), this medication sends strong signals to the brain that modulate hunger cues
2,8 In addition, if the patient has GI symptoms, including nausea, vomiting, retching, bloating, or abdominal pain, elective surgeries should be delayed
So, What Should We Take From This
The brand highlights clinical studies on individual ingredients rather than the full product , which means theres no clinical evidence proving its effectiveness for weight loss or metabolic health
This isn't a trend or an unproven supplement